Activation of GLP-1 leads to lower blood sugar levels and reduced food intake, contributing to healthy weight maintenance
Abstract Glucagon-like peptide-1 (GLP-1) medicines reduce food intake, body weight, insulin resistance and inflammation, thus improving outcomes for people with type 2 diabetes and obesity and potentially contributing to decreased cancer incidence
doi: 10.1172/JCI610 12 FarkasIVastaghCFarkasEBlintFSkrapitsKHrabovszkyEet al
GLP-1, or glucagon-like peptide-1, is a naturally occurring gut hormone released by intestinal L-cells in response to food intake
It also offers flexibility, allowing you to adjust portion size while keeping structure intact
Burrows DJ, McGown A, Jain SA, De Felice M, Ramesh TM, Sharrack B et al